Literature DB >> 18259191

HtrA2 enhances the apoptotic functions of p73 on bax.

M Marabese1, M Mazzoletti, F Vikhanskaya, M Broggini.   

Abstract

Regulation of the p73 gene is complex due to the presence of two promoters and the very complex mRNA maturation in both the N-terminal and C-terminal parts of the protein. We have found an additional regulation mechanism for the p73-alpha form that occurs through proteolytic cleavage connected to the activity of the serine protease HtrA2. Following apoptotic stimuli, HtrA2 accumulates in the nucleus and cleaves p73alpha in the C-terminal portion, enabling the protein to increase its transactivation activity on the apoptotic gene bax but not on the cell-cycle regulator gene p21. In the presence of HtrA2, p73 is more prone to cause caspase activation and nuclei fragmentation: p73 needs HtrA2 to activate and enhance its apoptotic functions. This new relation between p73 and HtrA2 may help to understand the different behavior of the p73 protein in cell physiology and in the responses of cancer cells to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259191     DOI: 10.1038/cdd.2008.7

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  12 in total

Review 1.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

Review 2.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

Review 3.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

4.  Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

5.  HtrA2, taming the oncogenic activities of WT1.

Authors:  Jörg Hartkamp; Stefan G E Roberts
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

6.  ∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

Authors:  Elisa Caiola; Eleonora Marrazzo; Simona Alesci; Massimo Broggini; Mirko Marabese
Journal:  Tumour Biol       Date:  2015-09-04

7.  Protease Omi facilitates neurite outgrowth in mouse neuroblastoma N2a cells by cleaving transcription factor E2F1.

Authors:  Qi Ma; Qing-song Hu; Ran-jie Xu; Xue-chu Zhen; Guang-hui Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08       Impact factor: 6.150

8.  THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.

Authors:  Meenakshi P Balakrishnan; Lucia Cilenti; Zineb Mashak; Paiyal Popat; Emad S Alnemri; Antonis S Zervos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

9.  Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.

Authors:  Elisa Caiola; Daniela Salles; Roberta Frapolli; Monica Lupi; Giuseppe Rotella; Anna Ronchi; Marina Chiara Garassino; Nikola Mattschas; Stefano Colavecchio; Massimo Broggini; Lisa Wiesmüller; Mirko Marabese
Journal:  Oncotarget       Date:  2015-10-06

10.  p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion.

Authors:  Shota Yamauchi; Yan Yan Hou; Alvin Kunyao Guo; Hiroaki Hirata; Wataru Nakajima; Ai Kia Yip; Cheng-han Yu; Ichiro Harada; Keng-Hwee Chiam; Yasuhiro Sawada; Nobuyuki Tanaka; Keiko Kawauchi
Journal:  J Cell Biol       Date:  2014-03-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.